Pliant Therapeutics (NASDAQ:PLRX) just reported results for the first quarter of 2024.
- Pliant Therapeutics reported earnings per share of -78 cents. This was below the analyst estimate for EPS of -77 cents.
- The company did not report any revenue for the quarter.